SCHEMBL4615

SCHEMBL4615

CC(C)(C)c1ccc(N2CC[C@]3(CC[C@@](O)(C(F)(F)F)CC3)C2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.42
CYP3A4 P08684 10/20 0.37
USP2 O75604 5/20 0.36
HIF1A Q16665 5/20 0.36
CYP2C19 P33261 3/20 0.36
CYP2C9 P11712 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP1A2 P05177 2/20 0.36
ALOX15 P16050 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 3/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 3/20 0.35
NPC1 O15118 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5548 0.81 CYP3A4 (0.36) HSD11B1CYP3A4USP2HIF1ACYP2C19
SCHEMBL25675738 0.80 HSD11B1 (0.40) HSD11B1CYP3A4USP2HIF1ACYP2C19
SCHEMBL5651 0.79 LIPE (0.38) HSD11B1CYP3A4USP2HIF1ACYP2C19
SCHEMBL5989 0.78 CYP3A4 (0.40) CYP3A4USP2HIF1ACYP2C19CYP2C9
SCHEMBL5559 0.77 FFAR4 (0.39) HSD11B1CYP3A4USP2HIF1ACYP2C19
SCHEMBL25675741 0.77 HSD11B1 (0.40) HSD11B1CYP3A4USP2HIF1ACYP2C19
SCHEMBL5391 0.75 CYP3A4 (0.35) CYP3A4USP2HIF1ACYP2C19CYP2C9
SCHEMBL4617 0.75 CYP3A4 (0.42) HSD11B1CYP3A4USP2HIF1ACYP2C19
SCHEMBL24124025 0.72 HSD11B1 (0.41) HSD11B1USP2CYP2C19CYP2C9ALDH1A1
SCHEMBL5760 0.71 ALDH1A1 (0.35) HSD11B1CYP3A4USP2HIF1ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed